Equities Analysts Issue Forecasts for Transcat, Inc.’s FY2025 Earnings (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – Investment analysts at HC Wainwright lowered their FY2025 earnings per share (EPS) estimates for shares of Transcat in a note issued to investors on Tuesday, April 16th. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will earn $2.31 per share for the year, down from their prior estimate of $2.41. HC Wainwright currently has a “Buy” rating and a $124.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.33 per share.

A number of other analysts have also issued reports on the company. TheStreet raised Transcat from a “c+” rating to a “b” rating in a report on Wednesday, January 31st. Oppenheimer reissued an “outperform” rating and set a $125.00 price objective (up previously from $120.00) on shares of Transcat in a report on Thursday.

Transcat Stock Performance

TRNS opened at $105.25 on Thursday. The firm has a market capitalization of $929.36 million, a P/E ratio of 80.96 and a beta of 0.59. The stock’s 50 day moving average price is $108.59 and its two-hundred day moving average price is $101.91. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. Transcat has a 12-month low of $74.89 and a 12-month high of $115.41.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $65.17 million for the quarter, compared to analyst estimates of $63.36 million. Transcat had a return on equity of 9.32% and a net margin of 4.16%.

Hedge Funds Weigh In On Transcat

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Wasatch Advisors LP boosted its stake in Transcat by 7.9% in the first quarter. Wasatch Advisors LP now owns 756,220 shares of the scientific and technical instruments company’s stock worth $84,266,000 after purchasing an additional 55,121 shares in the last quarter. Diversified Trust Co boosted its stake in Transcat by 23.6% in the first quarter. Diversified Trust Co now owns 3,010 shares of the scientific and technical instruments company’s stock worth $335,000 after purchasing an additional 575 shares in the last quarter. Annex Advisory Services LLC boosted its stake in Transcat by 6.1% in the first quarter. Annex Advisory Services LLC now owns 9,155 shares of the scientific and technical instruments company’s stock worth $1,020,000 after purchasing an additional 526 shares in the last quarter. Vanguard Group Inc. boosted its stake in Transcat by 12.3% in the fourth quarter. Vanguard Group Inc. now owns 477,799 shares of the scientific and technical instruments company’s stock worth $52,238,000 after purchasing an additional 52,421 shares in the last quarter. Finally, American International Group Inc. boosted its stake in Transcat by 10.6% in the fourth quarter. American International Group Inc. now owns 4,077 shares of the scientific and technical instruments company’s stock worth $446,000 after purchasing an additional 392 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Insider Transactions at Transcat

In related news, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the completion of the transaction, the director now owns 22,678 shares in the company, valued at approximately $2,562,614. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CEO Lee D. Rudow sold 2,373 shares of the firm’s stock in a transaction that occurred on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the transaction, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the transaction, the director now owns 22,678 shares of the company’s stock, valued at approximately $2,562,614. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,073 shares of company stock valued at $900,023. 4.20% of the stock is owned by corporate insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.